(Q35738153)

10 August 2017

1 reference

title

The aging male: testosterone deficiency and testosterone replacement. An up-date (English)

1 reference

10 August 2017

1 reference

1 reference

Peter Alexandersen

1

1 reference

PubMed ID

15064089

10 August 2017

Claus Christiansen

series ordinal

2

1 reference

10 August 2017

1 April 2004

1 reference

10 August 2017

1 reference

10 August 2017

173

1 reference

10 August 2017

2

1 reference

10 August 2017

157-169

1 reference

The relationship of natural androgens to coronary heart disease in males: a review

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

The effects of testosterone on insulin sensitivity in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone (DHEA) ameliorates the insulin sensitivity in older rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of obesity and body fat distribution on sex hormones and insulin in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Androgen receptors and skeletal muscle composition in trotters treated with nandrolone laureate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effects of hindlimb suspension and androgen treatment on testosterone receptors in rat skeletal muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Plasminogen activator inhibitor in plasma is related to testosterone in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effects in mice of testosterone and dihydrotestosterone on platelet aggregation in injured arterioles and ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Increase of blood fibrinolytic activity by testosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone and other anabolic steroids as cardiovascular drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Immune-endocrine interactions in the mammalian adrenal gland: facts and hypotheses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

C-reactive protein: structural biology, gene expression, and host defense function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Prospective study of effect of androgens on serum inflammatory markers in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

The relationship between sex hormones and high-density lipoprotein cholesterol levels in healthy adult men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Urinary excretion of testosterone and estradiol in Chinese men and relationships with serum lipoprotein concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Relationships of plasma estradiol, testosterone, and sex hormone-binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein subfractions in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Randomized clinical trial of testosterone replacement therapy in hypogonadal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Cardiovascular protection by oestrogen--a calcium antagonist effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of acute testosterone on myocardial ischemia in men with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Acute anti-ischemic effect of testosterone in men with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone propionate therapy in one hundred cases of angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of testosterone cypionate on postexercise ST segment depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone relaxes rabbit coronary arteries and aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone inhibits prostacyclin production by rat aortic smooth muscle cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

The effects of testosterone on lipids and eicosanoids in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of testosterone treatment on vasoconstrictor response of left anterior descending coronary artery in male and female pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Estrogen-mediated neuroprotection after experimental stroke in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Decreased serum testosterone in men with acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone Effects upon Photic Stimulation of the Electroencephalogram (EEG) and Mental Performance of Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Effects of infused testosterone on mental performances and serum LH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone influences spatial cognition in older men.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Gender differences in mathematics performance: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone, estradiol, ACTH and musical, spatial and verbal performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Serum testosterone in violent and nonviolent young offenders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

DHEA deficiency syndrome: a new term for old age?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Pharmacogenetics of human androgens and prostatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Testosterone replacement therapy in older adult men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Aromatase mRNA levels in benign prostatic hyperplasia and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

Risks versus benefits of testosterone therapy in elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900242-9

10.1016/S0021-9150(03)00242-9

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15064089